Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
The CEI is the technology transfer department of the University of Southampton. We are responsible for IP protection, licenses, spinouts and entrepreneurship throughout the University More
Peptor based in Israel and Germany, is engaged in the discovery and development of novel therapies for the treatment of human autoimmune diseases and cancers. More
Roche Protein Expression Group provides access to high-value therapeutic targets and peptides! More
BioFocus is a leading integrated drug discovery company that provides a range of products, programmes, lead series and services to pharmaceutical and biotechnology partners on a global basis. More
Muti-disciplinary institute with neuroscience, cancer and cardiovascular research toghether with medicinal chemistry expertise More
The University of Alberta is one of the five top research universities in Canada. More
A biopharmaceutical company engaged in functional genomics-based drug discovery and development. More
Your selection
Browse By
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2009 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us